AstraZeneca to supply Europe with up to 400 million doses of Oxford University’s vaccine at no profit

This article was originally published here

With today’s agreement, the IVA aims to accelerate the supply of the vaccine and to make it available to other European countries that wish to participate in the

The post AstraZeneca to supply Europe with up to 400 million doses of Oxford University’s vaccine at no profit appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply